TITLE

Knowledge characteristics and the dynamics of technological alliances in pharmaceuticals: empirical evidence from Europe, US and Japan

AUTHOR(S)
Krafft, Jackie; Quatraro, Francesco; Saviotti, Pier
PUB. DATE
July 2014
SOURCE
Journal of Evolutionary Economics;Jul2014, Vol. 24 Issue 3, p587
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The paper investigates the co-evolutionary patterns of the dynamics of technological alliances and of the structure of the knowledge base in the pharmaceutical sector. The main hypothesis under scrutiny is that technological alliances represent a key resource for firms in knowledge intensive sectors to cope with dramatic changes in the knowledge base, marked by the introduction of discontinuities opening up new technological trajectories. Using patent information and data on technological alliances drawn from the CATI-MERIT database, we compare the evidence concerning the so-called triad regions, i.e. United States, Europe and Japan. The empirical results support the existence of a life cycle in biotechnology affecting the pharmaceutical industry. Furthermore, the dynamics of alliances is found to depend on (i) the phase of the biotechnology life cycle, (ii) the strength of the region in biotechnology and (iii) the general features of the economic environment of the region.
ACCESSION #
96927606

 

Related Articles

  • Quide3l gains FDA approval for rapid flu test. Webb // San Diego Business Journal;10/11/99, Vol. 20 Issue 41, p29 

    Cites developments concerning biotechnology companies in the San Diego, California area as of October 11, 1999. Includes Quidel Corp.'s receipt of government approval for the marketing of its QuickVue Influenza Test in the United States; Idec Pharmaceuticals Corp.'s testing of the Idec-114 drug...

  • Employment and management trends in the biotechnolgy industry. Larbey, Cynthia // Journal of Commercial Biotechnology;Spring2002, Vol. 8 Issue 4, p298 

    This paper takes a look at the major influences on the biotechnology industry and how they are currently affecting employment and management trends. It takes a brief look at the impact of the economic environment, the pharmaceutical industry, the role of geography, the employment stages faced by...

  • Financing Picks Up. Burrill, G. Steven // BioPharm International;Sep2001, Vol. 14 Issue 9, p48 

    Discusses the financial recovery of biotechnology companies in the United States and Europe. Predictions regarding increased merger and acquisition activity within the industry; Market value of the U.S. biotechnology market; Prediction that investments in the industry is likely to improve in...

  • Biopharmaceuticals set for change.  // Chemical Market Reporter;04/07/97, Vol. 251 Issue 14, p7 

    Cites the changes in store for the biopharmaceutical industry in the United States as gleaned from study conducted by Decision Resources. Change in relationships with biotechnology companies; Investment in smaller biotechnology-oriented companies; Changing technological base of the...

  • Pharmaceutical and Biotech Sectors Drive Cleanroom Market Growth. Miller, George // Pharmaceutical Technology;Mar2003, Vol. 27 Issue 3, p20 

    Discusses the impact of technology advances and market growth in the pharmaceutical and biotechnology fields on the contamination control market in the U.S. Forecasted sales of cleanroom hardware and consumables worldwide by 2004; Forecasted value of worldwide cleanroom consumables market in...

  • Pharmaceutical Scientists in Today's Job Market . . . . Part I: An Industry in Turmoil. Dougherty, Eileen; Joslin, Robert S. // Pharmaceutical Technology;Mar2003, Vol. 27 Issue 3, p228 

    Part I. Outlines the profile of the pharmaceutical and biotechnology industries in the U.S., in 2003. Economic and political factors affecting the performance of the industry; Key to investments in research and development; Impact of the radical changes on employment opportunities and career...

  • An Industry Comes of Age. Robinson, Kevin // BioPharm International;Nov2002, Vol. 15 Issue 11, p20 

    Offers a look at the progress of biotechnology industries in Europe as of 2002. Revenues of the industry in 2000; Relationship between the pharmaceutical and the biotechnology industries; Factors which have contributed to the growth of the industry.

  • New threat for biotechs -- Europe. Fikes, Bradley J. // San Diego Business Journal;10/10/94, Vol. 15 Issue 41, p1 

    Reports on the potential competition posed by biotechnology companies in Europe to the United States biotechnology industry. Simplification of approval process for biotech drugs by the European Community to encourage drug manufacturers and to entice other manufacturers to set up plants in...

  • ...but seeks `practical' gene therapy deals. Lehrman, Sally // Nature;11/2/1995, Vol. 378 Issue 6552, p7 

    Reports on the support of pharmaceutical companies for gene-based medicine. Discouraging clinical trials for experimental gene therapies; Hoecgst Marion Roussel (HMR); Background information; Rhone Poulenc Rorer (RPR); Implications; SmithKline Beecham; Expectations.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics